CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Incidence of Acute Endophthalmitis after Intravitreal Antivascular Endothelial Growth Factor Injection in Age-related Macular Degeneration
Hyo Jin Seong, Young Min Park, Jiwon Kim, Kang Ju Son, Eun Jee Chung
Korean J Ophthalmol. 2022;36(5):435-442.   Published online August 19, 2022
DOI: https://doi.org/10.3341/kjo.2022.0088

Excel Download

Incidence of Acute Endophthalmitis after Intravitreal Antivascular Endothelial Growth Factor Injection in Age-related Macular Degeneration
Korean Journal of Ophthalmology. 2022;36(5):435-442   Crossref logo
Link1 Link2 Link3

Antivascular Endothelial Growth Factor Treatment Might Be Continued Even After Vitrectomy for Endophthalmitis in Neovascular Age-Related Macular Degeneration
Journal of VitreoRetinal Diseases. 2019;4(1):6-12   Crossref logo
Link1 Link2 Link3

Intraocular pressure changes after repeated intravitreal antivascular endothelial growth factor injections in patients with neovascular age-related macular degeneration with or without glaucoma
Taiwan Journal of Ophthalmology. 2014;4(1):28-32   Crossref logo
Link1 Link2

Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
Drug Design, Development and Therapy. 2013;485   Crossref logo
Link1

Choroidal Thickness Changes After Intravitreal Antivascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration: Ranibizumab Versus Aflibercept
Journal of Ocular Pharmacology and Therapeutics. 2015;31(6):357-362   Crossref logo
Link1 Link2

Response to: Comment on: Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
Eye. 2021;36(2):474-474   Crossref logo
Link1 Link2 Link3

Comment on “Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration”
Eye. 2021;36(2):477-477   Crossref logo
Link1 Link2 Link3

Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
. 2019;   Crossref logo
Link1 Link2

Incidence of Retinal Pigment Epithelial Tears after Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration
Yearbook of Ophthalmology. 2012;2012:140-142   Crossref logo
Link1 Link2

Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
. 2019;   Crossref logo
Link1 Link2